摘要:
An adjuvant of fluorocarbon emulsions for HIFU therapy, which can increase energy deposition in target regions during the therapy, comprises a discontinuous phase consisting of a core encapsuled by a film-forming material and a continuous phase consisting of aqueous medium, wherein the discontinuous phase is well distributed in the continuous one; the particle size of the discontinuous phase is 0.1-2µm; the amount of the film-forming material in the adjuvant is 0.1-100g/L; the core material used is a liquid which performs the liquid-gas phase transition at 38-100°C and is incorporated into the adjuvant in the amount of 5-200ml/L. The adjuvant of fluorocarbon emulsions for HIFU therapy is capable of upgrading the acoustic environment of target regions remarkably, increasing energy deposition in target tissues during HIFU therapy, and consequently significantly improving the damaging effect against tumor cells during clinical HIFU. And the usage of such adjuvant in HIFU therapy.
摘要:
The present invention generally relates to a medical apparatus. More particularly, the present invention relates to an apparatus for delivering a medium to body cavity of mammals including a human, especially to an apparatus for expanding rectum. Specifically, the present invention relates to the field of focused ultrasound treatment with a main purpose to provide an auxiliary device for ultrasound therapy applied to uterine myoma so as to avoid damage by ultrasound after focused within body. Therefore, the present invention provides an apparatus for blocking ultrasound, comprising (1) lead-in means for entering into said body cavity; and (2) accommodation means for containing ultrasound blocking medium, which enwraps the lead-in means outside.
摘要:
The present invention discloses a plasmid enhancement agent for high intensity focused ultrasound (HIFU) treatment, which can increase acoustic energy deposition at the target location during HIFU treatment. The enhancement agent comprises a nanometer-sized biocompatible solid. The present invention also discloses another plasmid enhancement agent for HIFU treatment, wherein, the enhancement agent comprises a discontinuous phase is comprised of a core material encapsulated by a membrane-forming material, and a continuous phase comprised of aqueous medium; the discontinuous phase is uniformly dispersed in the continuous phase and has a particle size ranging from 10-1000nm; the amount of the membrane-forming material in the enhancement agent is 0.1-100g/L; and the core material comprises nanometer-sized biocompatible solid selected from the group consisting of magnetic biomaterials, hydroxylapatite, and calcium carbonate, and the amount of the core material in the enhancement agent is 0.1-150g/L. The plasmid enhancement agent for HIFU treatment of the present invention can significantly change the acoustic environment of the target location and can increase acoustic energy deposition at the target location during HIFU treatment. Eventually, the effectiveness of clinical HIFU treatment to ablate the tumor cells can be significantly improved. Accordingly, the present invention discloses use of the above plasmid enhancement agent for HIFU treatment during HIFU treatment.
摘要:
The present invention discloses a particle enhancement agent for high intensity focused ultrasound (HIFU) treatment, which can increase acoustic energy deposition at the target location during HIFU treatment. The enhancement agent comprises a discontinuous phase comprised of a core material encapsulated by a membrane-forming material and a continuous phase comprising of aqueous medium. The discontinuous phase is uniformly dispersed in the continuous phase and the particle size of the discontinuous phase ranges from 0.1-8µm; the amount of the membrane-forming material in the enhancement agent is 0.1-100g/L; the core material is comprised of a liquid that does not undergo a liquid-gas phase transition at 38-100°C, and the amount of core material in the enhancement agent is 5-200g/L. The particle enhancement agent for HIFU treatment of the present invention can significantly change the acoustic environment of the target location and can increase acoustic energy deposition at the target location during HIFU treatment. Eventually, the ability of clinical HIFU treatment to ablate tumor cells can be significantly improved. Accordingly, the present invention discloses use of a particle enhancement agent for HIFU treatment during HIFU treatment.
摘要:
An ultrasonic transducer is disclosed, which includes one or a plurality of ultrasonic emitting units. Wavefronts of the ultrasonic waves emitted by the one or the plurality of ultrasonic emitting units are sphere surfaces with uniform radius, and the one or the plurality of ultrasonic emitting units can reflect ultrasound. The one ultrasonic emitting unit is configured to form a spherical resonant cavity, or the plurality of ultrasonic emitting units are configured to form a spherical resonant cavity collectively. An internal cavity of the spherical resonant cavity has a spherical shell shape or a cross-sectional spherical shell shape with a spherical center therein. The ultrasonic waves emitted by the one or the plurality of ultrasonic emitting units are focused on an area in which the spherical center of the spherical resonant cavity is located. The ultrasonic transducer not only can be provided with a large ultrasonic emitting area and a great focusing gain that render the energy of the ultrasonic focus enhanced dramatically, but also can be free from the influence of work frequency of an ultrasonic source.
摘要:
The high intensity focused ultrasound therapeutic apparatus according to the invention comprises a ultrasonic transducer, an image sampling means, a drive unit for driving the'iultrasonic transducer and a movement mechanism for moving the ultrasonic transducer and the image sampling means. The high intensity focused ultrasound therapeutic apparatus further comprise a signal processing unit connected with the image sampling means, for accepting and saving the initial image from the target before the treatment is performed, and accepting and saving the image on a certain specific time during the high intensity focused ultrasound therapeutic process, and them estimating the treated effect based upon the before-treatment image and the after-treatment image, and a controller unit connected with the signal processing unit, the drive unit and the movement mechanism respectively controls the drive unit and the movement mechanism to stop the ultrasonic transducer if the signal processing unit determines that the expectant treatment effect have been obtained, and if the signal processing unit determines that the expectant treatment effect haven’t been obtained, controls the drive unit and the movement mechanism to go on.
摘要:
The invention provides an ultrasound therapeutic apparatus for treating skin lesions of human being, comprising a controlling device, an ultrasound transducer transmitting the therapeutic ultrasound beam to the subject, a focusing means. Said controlling device is the electrical control system of the ultrasound therapeutic apparatus. Said ultrasound transducer and said focusing means are placed in an ultrasound applicator, which can be held by hand. The ultrasound applicator, which can be held by hand, includes a handle and a housing forming a lumen and the said ultrasound transducer and said focusing means are placed in the said lumen. The ultrasound applicator can be held by clinicians' hand, performing a treatment on skin lesions of human being including the skin lesions of gynecology more conveniently.
摘要:
The present invention discloses an enhancement agent for high intensity focused ultrasound (HIFU) treatment, which is administered to a patient before HIFU treatment and can reduce the level of EEF at the target location to be treated with HIFU. EEF is presented by the expression: EEF = ηPt / v (unit: J/mm 3 ), and refers to the HIFU energy needed to effectively treat a tumor per unit volume of the tumor, wherein, η=0.7; P refers to the total acoustic power of HIFU source (unit: W); t refers to the total time of HIFU treatment (unit: s); V refers to the volume of HIFU-induced lesions (unit: mm 3 ). If the amount of EEF at the target location before administration of the enhancement agent is defined as EEF (base) and the amount of EEF at the target location after administration of the enhancement agent is defined as EEF (measurement) , the ratio between EEF (base) and EEF (measurement) is more than 1, preferably more than 2, and more preferably over 4. The use of the enhancement agent for HIFU treatment of the present invention makes it possible to treat deep-seated tumors. In addition, patients with hepatic tumors can be effectively treated without removal of ribs. Accordingly, the present invention discloses methods for increasing acoustic energy deposition at target location during HIFU treatment and screening the enhancement agents for HIFU treatment.
摘要:
The present invention discloses a fluoro-carbon emulsion enhancement agent for HIFU treatment, which can increase acoustic energy deposition at the target location during HIFU treatment. The enhancement agent comprises a discontinuous phase comprising of a core material encapsulated by a membrane-forming material and a continuous phase comprised of aqueous medium; the discontinuous phase is uniformly dispersed in the continuous phase and the particle size of the discontinuous phase ranges from 0.1-2µm; the amount of the membrane-forming material in the enhancement agent is 0.1-100g/L; the core material is comprised of a liquid that undergoes a liquid-gas phase transition at 38-100°C, and the amount of the core material in the enhancement agent is 5-200ml/L. The fluoro-carbon emulsion enhancement agent for HIFU treatment of the present invention can significantly change the acoustic environment of the target location and can increase acoustic energy deposition at the target location during HIFU treatment. Eventually, the ability of clinical HIFU treatment to ablate tumor cells can be significantly improved. Accordingly, the present invention discloses use of a fluoro-carbon emulsion enhancement agent for HIFU treatment during HIFU treatment.